Last reviewed · How we verify
Proteus septicemia
Approved treatments
- Ramycin
Fusidic acid works by inhibiting the function of the bacterial ribosome, preventing the production of essential proteins. - Garamycin · Merck & Co.
- Unasyn · Bristol-Myers Squibb
- Pipracil
Pipracil works by inhibiting bacterial cell wall synthesis, ultimately leading to cell lysis and death. - Gentamicin · Merck & Co.
- Azactam · Bristol-Myers Squibb
Aztreonam inhibits bacterial cell wall synthesis, acting as a bactericidal agent. - Arikayce Kit · Bristol-Myers Squibb
Amikacin works by binding to bacterial ribosomes, inhibiting protein synthesis and ultimately killing the bacteria. - TICARCILLIN
- Ticarcillin
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Proteus septicemia patent landscape — cliff calendar, originator estates, attackable patents
- Proteus septicemia treatment landscape brief
- Proteus septicemia treatment updates RSS
Frequently asked questions about Proteus septicemia
What drugs treat Proteus septicemia?
Tracked treatments include Ramycin, Garamycin, Unasyn, Pipracil, Gentamicin, Azactam, Arikayce Kit, TICARCILLIN.
What is the treatment for Proteus septicemia?
Standard treatment for Proteus septicemia includes Ramycin, Garamycin, Unasyn, Pipracil, Gentamicin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Proteus septicemia patent cliff · Proteus septicemia CI report
- Treatment: Ramycin
- Treatment: Garamycin · Merck & Co.
- Treatment: Unasyn · Bristol-Myers Squibb
- Treatment: Pipracil
- Treatment: Gentamicin · Merck & Co.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing